---
document_datetime: 2026-01-20 11:40:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ponlimsi-epar-all-authorised-presentations_en.pdf
document_name: ponlimsi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.726875
conversion_datetime: 2026-01-22 21:23:45.151163
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.69.0
  docling-core: 2.60.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical form    | Route of administration   | Immediate Packaging        | Content (concentration)   | Pack size            |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|----------------------|
| EU/1/25/1986/001 | Ponlimsi          | 60 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1 ml (60 mg/ml)           | 1 pre-filled syringe |